Back to newsBioCryst Pharmaceuticals Inc <BCRX.O>: JP Morgan Resumes Coverage With Neutral Rating; Target Price $12BBCRX•2026-07-13Related NewsONasdaq trade halt continues <OST.O> reason not available at 03:58 AM
BCRX•BCRX•BCRX•BCRX•
